Brief: ProtoKinetix Announces The Resumption Of Phase 1B Clinical Trials For The Use Of Aagp® Treated Islet Cells In The Treatment Of Type 1 Diabetes

ProtoKinetix

22/04/2021 13:26

April 22 (Reuters) - ProtoKinetix Inc  PKTX.PK :
    * PROTOKINETIX ANNOUNCES THE RESUMPTION OF PHASE 1B CLINICAL
TRIALS FOR THE USE OF AAGP® TREATED ISLET CELLS IN THE TREATMENT
OF TYPE 1 DIABETES

Source text for Eikon:  ID:nBw4Ml8QMa 
Further company coverage:  PKTX.PK 

 ((Reuters.Briefs@thomsonreuters.com;))